These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14745184)

  • 1. Tomato paste fraction inhibiting the formation of advanced glycation end-products.
    Kiho T; Usui S; Hirano K; Aizawa K; Inakuma T
    Biosci Biotechnol Biochem; 2004 Jan; 68(1):200-5. PubMed ID: 14745184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of pentosidine and pyrraline in food and chemical models: formation, potential risks and determination.
    Li H; Yu SJ
    J Sci Food Agric; 2018 Jul; 98(9):3225-3233. PubMed ID: 29280151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation modification of Rosenthal fibers in patients with Alexander disease.
    Castellani RJ; Perry G; Harris PL; Monnier VM; Cohen ML; Smith MA
    Neurosci Lett; 1997 Aug; 231(2):79-82. PubMed ID: 9291145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
    Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
    Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
    Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
    Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.
    Cervantes-Laurean D; Schramm DD; Jacobson EL; Halaweish I; Bruckner GG; Boissonneault GA
    J Nutr Biochem; 2006 Aug; 17(8):531-40. PubMed ID: 16443355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
    Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
    Odetti P; Traverso N; Cosso L; Noberasco G; Pronzato MA; Marinari UM
    Diabetologia; 1996 Dec; 39(12):1440-7. PubMed ID: 8960824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
    Miyata T; Ueda Y; Asahi K; Izuhara Y; Inagi R; Saito A; VAN Ypersele DE Strihou C; Kurokawa K
    J Am Soc Nephrol; 2000 Sep; 11(9):1719-1725. PubMed ID: 10966497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee leaf extract inhibits advanced glycation end products and their precursors: A mechanistic study.
    Sun Y; Xie W; Huang Y; Chen X
    J Food Sci; 2024 Jun; 89(6):3455-3468. PubMed ID: 38700315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
    Castellani R; Smith MA; Richey PL; Perry G
    Brain Res; 1996 Oct; 737(1-2):195-200. PubMed ID: 8930366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of AGE-precursors and AGE formation in glycation-induced BSA peptides.
    Ahmad W; Li L; Deng Y
    BMB Rep; 2008 Jul; 41(7):516-22. PubMed ID: 18682035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentosidine in advanced glycation end-products (AGEs) during UVA irradiation generates active oxygen species and impairs human dermal fibroblasts.
    Okano Y; Masaki H; Sakurai H
    J Dermatol Sci; 2001 Aug; 27 Suppl 1():S11-8. PubMed ID: 11514120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2'-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species.
    Rafi Z; Alouffi S; Khan MS; Ahmad S
    Curr Protein Pept Sci; 2020; 21(9):924-935. PubMed ID: 32053073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
    Nangaku M; Miyata T; Sada T; Mizuno M; Inagi R; Ueda Y; Ishikawa N; Yuzawa H; Koike H; van Ypersele de Strihou C; Kurokawa K
    J Am Soc Nephrol; 2003 May; 14(5):1212-22. PubMed ID: 12707391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins.
    Westwood ME; Thornalley PJ
    J Protein Chem; 1995 Jul; 14(5):359-72. PubMed ID: 8590604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.